These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31839016)

  • 1. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Zhang T; Xu L; Li H; Woodberry KA; Kline ER; Jiang J; Cui H; Tang Y; Tang X; Wei Y; Hui L; Lu Z; Cao L; Li C; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Psychol Med; 2021 Mar; 51(4):653-660. PubMed ID: 31839016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP.
    Zhang T; Yang S; Xu L; Tang X; Wei Y; Cui H; Li H; Tang Y; Hui L; Li C; Chen X; Wang J
    Psychol Med; 2020 Jul; 50(9):1578-1584. PubMed ID: 31451124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample.
    Osborne KJ; Mittal VA
    Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
    Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program.
    Zhang T; Li H; Tang Y; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; McCarley RW; Seidman LJ; Wang J
    Am J Psychiatry; 2018 Sep; 175(9):906-908. PubMed ID: 30173545
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China.
    Li H; Zhang T; Xu L; Tang Y; Cui H; Wei Y; Tang X; Woodberry KA; Shapiro DI; Li C; Seidman LJ; Wang J
    Schizophr Res; 2018 Jul; 197():509-515. PubMed ID: 29287626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized risk components guiding antipsychotic delivery in patients with a clinical high risk of psychosis: application of a risk calculator.
    Zhang T; Xu L; Li H; Cui H; Tang Y; Wei Y; Tang X; Hu Y; Hui L; Li C; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Psychol Med; 2021 Feb; ():1-10. PubMed ID: 33593473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
    Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
    Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
    Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
    Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state.
    Kotlicka-Antczak M; Karbownik MS; Stawiski K; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Fusar-Poli P
    Eur Psychiatry; 2019 May; 58():72-79. PubMed ID: 30870626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical subtypes that predict conversion to psychosis: A canonical correlation analysis study from the ShangHai At Risk for Psychosis program.
    Zhang T; Tang X; Li H; Woodberry KA; Kline ER; Xu L; Cui H; Tang Y; Wei Y; Li C; Hui L; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Aust N Z J Psychiatry; 2020 May; 54(5):482-495. PubMed ID: 31486343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis).
    Zhang T; Xu L; Tang X; Wei Y; Hu Q; Hu Y; Cui H; Tang Y; Hui L; Li C; Cao L; Lu Z; Wang J
    Aust N Z J Psychiatry; 2020 Jul; 54(7):696-706. PubMed ID: 32436725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.